These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 18482691

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of polo-like kinase 1 by blocking polo-box domain-dependent protein-protein interactions.
    Reindl W, Yuan J, Krämer A, Strebhardt K, Berg T.
    Chem Biol; 2008 May; 15(5):459-66. PubMed ID: 18482698
    [Abstract] [Full Text] [Related]

  • 3. A high-throughput assay based on fluorescence polarization for inhibitors of the polo-box domain of polo-like kinase 1.
    Reindl W, Strebhardt K, Berg T.
    Anal Biochem; 2008 Dec 15; 383(2):205-9. PubMed ID: 18793607
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Selectivity-determining residues in Plk1.
    Kothe M, Kohls D, Low S, Coli R, Rennie GR, Feru F, Kuhn C, Ding YH.
    Chem Biol Drug Des; 2007 Dec 15; 70(6):540-6. PubMed ID: 18005335
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification of green tea catechins as potent inhibitors of the polo-box domain of polo-like kinase 1.
    Shan HM, Shi Y, Quan J.
    ChemMedChem; 2015 Jan 15; 10(1):158-63. PubMed ID: 25196850
    [Abstract] [Full Text] [Related]

  • 12. Molecular and enzoinformatics perspectives of targeting Polo-like kinase 1 in cancer therapy.
    Shakil S, Baig MH, Tabrez S, Rizvi SMD, Zaidi SK, Ashraf GM, Ansari SA, Khan AAP, Al-Qahtani MH, Abuzenadah AM, Chaudhary AG.
    Semin Cancer Biol; 2019 Jun 15; 56():47-55. PubMed ID: 29122685
    [Abstract] [Full Text] [Related]

  • 13. Dynamic and multi-pharmacophore modeling for designing polo-box domain inhibitors.
    Sakkiah S, Senese S, Yang Q, Lee KW, Torres JZ.
    PLoS One; 2014 Jun 15; 9(7):e101405. PubMed ID: 25036740
    [Abstract] [Full Text] [Related]

  • 14. Identification of a novel Polo-like kinase 1 inhibitor that specifically blocks the functions of Polo-Box domain.
    Chen Y, Zhang J, Li D, Jiang J, Wang Y, Si S.
    Oncotarget; 2017 Jan 03; 8(1):1234-1246. PubMed ID: 27902479
    [Abstract] [Full Text] [Related]

  • 15. Modulation of the Allosteric Communication between the Polo-Box Domain and the Catalytic Domain in Plk1 by Small Compounds.
    Raab M, Sanhaji M, Pietsch L, Béquignon I, Herbrand AK, Süß E, Gande SL, Caspar B, Kudlinzki D, Saxena K, Sreeramulu S, Schwalbe H, Strebhardt K, Biondi RM.
    ACS Chem Biol; 2018 Aug 17; 13(8):1921-1931. PubMed ID: 29927572
    [Abstract] [Full Text] [Related]

  • 16. A fluorescence polarization assay for the discovery of inhibitors of the polo-box domain of polo-like kinase 1.
    Reindl W, Strebhardt K, Berg T.
    Methods Mol Biol; 2012 Aug 17; 795():69-81. PubMed ID: 21960216
    [Abstract] [Full Text] [Related]

  • 17. Differential Cellular Effects of Plk1 Inhibitors Targeting the ATP-binding Domain or Polo-box Domain.
    Shin SB, Woo SU, Yim H.
    J Cell Physiol; 2015 Dec 17; 230(12):3057-67. PubMed ID: 25975351
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo.
    Yuan J, Sanhaji M, Krämer A, Reindl W, Hofmann M, Kreis NN, Zimmer B, Berg T, Strebhardt K.
    Am J Pathol; 2011 Oct 17; 179(4):2091-9. PubMed ID: 21839059
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.